Physician profile
Aaron M Banta
NPI 1831166891
$1,340.25
in general payments reported to CMS, 2019-2025
13 companies · $49.11 in 2025
The $49.11 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $35.25 · 2021: $41.97 · 2022: $226 · 2023: $459 · 2024: $325 · 2025: $49.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.19 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $401.13 | 2019-2025 | Precision 1, Clareon, Tryptyr |
| Oyster Point Pharma, INC. | $150.51 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $144.40 | 2021-2022 | |
| Biotissue Holdings INC. | $124.25 | 2023-2024 | |
| Apellis Pharmaceuticals, INC. | $113.27 | 2023 | Syfovre |
| Abbvie INC. | $106.96 | 2022-2025 | Vuity |
| Coopervision INC. | $87.92 | 2023 | Misight Contact Lens |
| Bausch & Lomb Americas INC. | $59.25 | 2023-2024 | Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $54.12 | 2019-2023 | Cequa |
| Aerie Pharmaceuticals, INC. | $45.13 | 2019-2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.69 | 2019 | |
| Shire North American Group INC | $15.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Banta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.